Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Accéder directement au contenu
Article Dans Une Revue Cells Année : 2022

Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications

Résumé

Neurodegenerative diseases are incurable, heterogeneous, and age-dependent disorders that challenge modern medicine. A deeper understanding of the pathogenesis underlying neurodegenerative diseases is necessary to solve the unmet need for new diagnostic biomarkers and disease-modifying therapy and reduce these diseases’ burden. Specifically, post-translational modifications (PTMs) play a significant role in neurodegeneration. Due to its proximity to the brain parenchyma, cerebrospinal fluid (CSF) has long been used as an indirect way to measure changes in the brain. Mass spectrometry (MS) analysis in neurodegenerative diseases focusing on PTMs and in the context of biomarker discovery has improved and opened venues for analyzing more complex matrices such as brain tissue and blood. Notably, phosphorylated tau protein, truncated α-synuclein, APP and TDP-43, and many other modifications were extensively characterized by MS. Great potential is underlying specific pathological PTM-signatures for clinical application. This review focuses on PTM-modified proteins involved in neurodegenerative diseases and highlights the most important and recent breakthroughs in MS-based biomarker discovery.
Fichier principal
Vignette du fichier
cells-11-01279.pdf (1.94 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04403495 , version 1 (24-05-2024)

Licence

Identifiants

Citer

Rita Azevedo, Chloé Jacquemin, Nicolas Villain, François Fenaille, Foudil Lamari, et al.. Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications. Cells, 2022, 11 (8), pp.1279. ⟨10.3390/cells11081279⟩. ⟨hal-04403495⟩
8 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More